Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v6-EN
Language French English
Date Updated 2017-08-18 2017-08-18
Drug Identification Number 02410753 02410753
Brand name APO-LORAZEPAM SUBLINGUAL APO-LORAZEPAM SUBLINGUAL
Common or Proper name LORAZEPAM LORAZEPAM
Company Name AA PHARMA INC AA PHARMA INC
Ingredients LORAZEPAM LORAZEPAM
Strength(s) 1MG 1MG
Dosage form(s) TABLET TABLET
Route of administration SUBLINGUAL SUBLINGUAL
Packaging size 100 BTL 100 BTL
ATC code N05BA N05BA
ATC description ANXIOLYTICS ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-06-26 2017-06-26
Estimated end date 2017-08-09 2017-08-09
Actual end date 2017-08-15 2017-08-15
Shortage status Resolved Resolved
Company comments
Health Canada comments